Literature DB >> 26365195

Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area.

Huikun Wang1, Tyler Treadway1, Daniel P Covey2, Joseph F Cheer2, Carl R Lupica3.   

Abstract

Cocaine is a highly addictive drug that acts upon the brain's reward circuitry via the inhibition of monoamine uptake. Endogenous cannabinoids (eCB) are lipid molecules released from midbrain dopamine (DA) neurons that modulate cocaine's effects through poorly understood mechanisms. We find that cocaine stimulates release of the eCB, 2-arachidonoylglycerol (2-AG), in the rat ventral midbrain to suppress GABAergic inhibition of DA neurons, through activation of presynaptic cannabinoid CB1 receptors. Cocaine mobilizes 2-AG via inhibition of norepinephrine uptake and promotion of a cooperative interaction between Gq/11-coupled type-1 metabotropic glutamate and α1-adrenergic receptors to stimulate internal calcium stores and activate phospholipase C. The disinhibition of DA neurons by cocaine-mobilized 2-AG is also functionally relevant because it augments DA release in the nucleus accumbens in vivo. Our results identify a mechanism through which the eCB system can regulate the rewarding and addictive properties of cocaine.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26365195      PMCID: PMC4857883          DOI: 10.1016/j.celrep.2015.08.041

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  57 in total

1.  Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation.

Authors:  Joseph F Cheer; Kate M Wassum; Leslie A Sombers; Michael L A V Heien; Jennifer L Ariansen; Brandon J Aragona; Paul E M Phillips; R Mark Wightman
Journal:  J Neurosci       Date:  2007-01-24       Impact factor: 6.167

Review 2.  Reward system and addiction: what dopamine does and doesn't do.

Authors:  Gaetano Di Chiara; Valentina Bassareo
Journal:  Curr Opin Pharmacol       Date:  2006-12-15       Impact factor: 5.547

3.  Cannabinoid CB1 receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role of glutamate in the nucleus accumbens.

Authors:  Zheng-Xiong Xi; Jeremy G Gilbert; Xiao-Qing Peng; Arlene C Pak; Xia Li; Eliot L Gardner
Journal:  J Neurosci       Date:  2006-08-16       Impact factor: 6.167

4.  Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra.

Authors:  E D French; K Dillon; X Wu
Journal:  Neuroreport       Date:  1997-02-10       Impact factor: 1.837

5.  D1 receptors modulate glutamate transmission in the ventral tegmental area.

Authors:  P W Kalivas; P Duffy
Journal:  J Neurosci       Date:  1995-07       Impact factor: 6.167

Review 6.  How addictive drugs disrupt presynaptic dopamine neurotransmission.

Authors:  David Sulzer
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

7.  Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter.

Authors:  Morgane Thomsen; Dawn D Han; Howard H Gu; S Barak Caine
Journal:  J Pharmacol Exp Ther       Date:  2009-07-14       Impact factor: 4.030

8.  Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice.

Authors:  Xia Li; Alexander F Hoffman; Xiao-Qing Peng; Carl R Lupica; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Psychopharmacology (Berl)       Date:  2008-12-20       Impact factor: 4.530

9.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

Authors:  R Mechoulam; S Ben-Shabat; L Hanus; M Ligumsky; N E Kaminski; A R Schatz; A Gopher; S Almog; B R Martin; D R Compton
Journal:  Biochem Pharmacol       Date:  1995-06-29       Impact factor: 5.858

Review 10.  Ca(2+)-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities.

Authors:  Yuki Hashimotodani; Takako Ohno-Shosaku; Masanobu Kano
Journal:  Curr Opin Neurobiol       Date:  2007-04-06       Impact factor: 6.627

View more
  37 in total

1.  Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid-Dependent Lipid Signaling.

Authors:  Stephanie C Gantz; Bruce P Bean
Journal:  Neuron       Date:  2017-03-02       Impact factor: 17.173

2.  Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease.

Authors:  Dan P Covey; Hannah M Dantrassy; Samantha E Yohn; Alberto Castro; P Jeffrey Conn; Yolanda Mateo; Joseph F Cheer
Journal:  Neuropsychopharmacology       Date:  2018-06-01       Impact factor: 7.853

3.  Cannabinoids Stimulate the TRP Channel-Dependent Release of Both Serotonin and Dopamine to Modulate Behavior in C. elegans.

Authors:  Mitchell Oakes; Wen Jing Law; Richard Komuniecki
Journal:  J Neurosci       Date:  2019-03-18       Impact factor: 6.167

4.  Endocannabinoid Regulation of Cocaine Reinforcement: an Upper or Downer?

Authors:  Dan P Covey; Natalie E Zlebnik; Joseph F Cheer
Journal:  Neuropsychopharmacology       Date:  2016-08       Impact factor: 7.853

Review 5.  Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.

Authors:  Natalie E Zlebnik; Joseph F Cheer
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

6.  PDE4 Inhibition Restores the Balance Between Excitation and Inhibition in VTA Dopamine Neurons Disrupted by Repeated In Vivo Cocaine Exposure.

Authors:  Xiaojie Liu; Peng Zhong; Casey Vickstrom; Yan Li; Qing-Song Liu
Journal:  Neuropsychopharmacology       Date:  2017-05-02       Impact factor: 7.853

7.  CB1 Receptor Signaling Modulates Amygdalar Plasticity during Context-Cocaine Memory Reconsolidation to Promote Subsequent Cocaine Seeking.

Authors:  Jessica A Higginbotham; Rong Wang; Ben D Richardson; Hiroko Shiina; Shi Min Tan; Mark A Presker; David J Rossi; Rita A Fuchs
Journal:  J Neurosci       Date:  2020-11-30       Impact factor: 6.167

8.  Cocaine self-administration abolishes endocannabinoid-mediated long-term depression of glutamatergic synapses in the ventral tegmental area.

Authors:  Ruixiang Wang; Kathryn A Hausknecht; Amy M Gancarz-Kausch; Saida Oubraim; Roh-Yu Shen; Samir Haj-Dahmane
Journal:  Eur J Neurosci       Date:  2020-09-30       Impact factor: 3.386

Review 9.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

10.  Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids.

Authors:  Dan P Covey; Kendra D Bunner; Douglas R Schuweiler; Joseph F Cheer; Paul A Garris
Journal:  Eur J Neurosci       Date:  2016-05-11       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.